Vulnerability · CVE-2026-3429
A flaw was identified in the Account REST API of Keycloak that allows a user authenticated at a lower security level to perform sensitive actions intended only for hig…
Published Mar 11, 2026 · catalog updated Aug 18, 2026 · build of keycloak
Check if you run it
No confirmed exploitation is on record for CVE-2026-3429. EPSS is 0.33%. Act only if a listed version of build of keycloak is installed.
Gaps on this record
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium4.2
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.33%
- Remediation
- Advisory link
- Affected products
- cpe redhat/build of keycloak
A flaw was identified in the Account REST API of Keycloak that allows a user authenticated at a lower security level to perform sensitive actions intended only for higher-assurance sessions. Specifically, an attacker who has already obtained a victim’s password can delete the victim’s registered MFA/OTP credential without first proving possession of that factor. The attacker can then register their own MFA device, effectively taking full control of the account. This weakness undermines the intended protection provided by multi-factor authentication.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe redhat/build of keycloakversion unspecified
How to fix CVE-2026-3429
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-3429. EPSS is 0.33%. Act only if a listed version of build of keycloak is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-284: Improper Access Control. EPSS 0.33%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Mar 11, 2026 · NIST NVD
Detected
A flaw was identified in the Account REST API of Keycloak that allows a user authenticated at a lower security level to perform sensitive actions intended only for higher-assurance sessions. Specifically, an attacker who has already obtained a victim’s password can delete the victim’s registered MFA/OTP credential without first proving possession of that factor. The attacker can then register thei
Aug 18, 2026 · NIST NVD
Updated
A flaw was identified in the Account REST API of Keycloak that allows a user authenticated at a lower security level to perform sensitive actions intended only for higher-assurance sessions. Specifically, an attacker who has already obtained a victim’s password can delete the victim’s registered MFA/OTP credential without first proving possession of that factor. The attacker can then register thei
Sources
- CVE.orgVulnerability recordCVE-2026-3429
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-3429
30-day exploitation probability 0.3%
first.org - NIST NVDVulnerability recordCVE-2026-3429
A flaw was identified in the Account REST API of Keycloak that allows a user authenticated at a lower security level to perform sensitive actions intended only for higher-assurance sessions. Specifically, an attacker who has already obtained a victim’s password can delete the vic
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.